Soltis Investment Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,190	Closed	-$216K	–	244
2021 Q2	$216K	Buy	+2,190	New	+$216K	0.03%	227
2021 Q1	–	Sell	-2,747	Closed	-$237K	–	215
2020 Q4	$237K	Buy	+2,747	New	+$237K	0.04%	197